Steven Cohen's TMO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 169,451 shares of Thermo Fisher Scientific Inc. (TMO) worth $82.19 M, representing 0.14% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 423,584 shares. Largest reduction occurred in Q1 2024, reducing 383,912 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +148,401 | Add 0.00% | 148,400 | $118.00 |
| Q3 2014 | -68,600 | Reduce 46.23% | 79,800 | $121.70 |
| Q4 2014 | +159,900 | Add 200.38% | 239,700 | $125.29 |
| Q1 2015 | -239,700 | Sold Out | 0 | $0.00 |
| Q2 2015 | +33,300 | New Buy | 33,300 | $129.76 |
| Q3 2015 | -31,500 | Reduce 94.59% | 1,800 | $122.22 |
| Q4 2015 | -300 | Reduce 16.67% | 1,500 | $142.00 |
| Q1 2016 | -1,500 | Sold Out | 0 | $0.00 |
| Q4 2016 | +183,552 | New Buy | 183,552 | $141.10 |
| Q1 2017 | -183,552 | Sold Out | 0 | $0.00 |
| Q2 2017 | +126,605 | New Buy | 126,605 | $174.47 |
| Q3 2017 | -91,605 | Reduce 72.35% | 35,000 | $189.20 |
| Q4 2017 | -35,000 | Sold Out | 0 | $0.00 |
| Q1 2018 | +316,138 | New Buy | 316,138 | $206.46 |
| Q2 2018 | -306,138 | Reduce 96.84% | 10,000 | $207.10 |
| Q3 2018 | +47,300 | Add 473.00% | 57,300 | $244.08 |
| Q4 2018 | -57,300 | Sold Out | 0 | $0.00 |
| Q4 2019 | +12,700 | New Buy | 12,700 | $324.88 |
| Q1 2020 | -12,700 | Sold Out | 0 | $0.00 |
| Q2 2020 | +13,936 | New Buy | 13,936 | $362.37 |
| Q3 2020 | +75,689 | Add 543.12% | 89,625 | $441.52 |
| Q4 2020 | -55,044 | Reduce 61.42% | 34,581 | $465.78 |
| Q1 2021 | -14,626 | Reduce 42.29% | 19,955 | $456.38 |
| Q2 2021 | -12,747 | Reduce 63.88% | 7,208 | $504.44 |
| Q3 2021 | +245,753 | Add 3409.45% | 252,961 | $571.33 |
| Q4 2021 | -153,143 | Reduce 60.54% | 99,818 | $667.24 |
| Q1 2022 | -72,757 | Reduce 72.89% | 27,061 | $590.67 |
| Q2 2022 | -27,061 | Sold Out | 0 | $0.00 |
| Q2 2023 | +1,601 | New Buy | 1,601 | $521.75 |
| Q3 2023 | -1,382 | Reduce 86.32% | 219 | $506.11 |
| Q4 2023 | +423,584 | Add 193417.34% | 423,803 | $530.79 |
| Q1 2024 | -383,912 | Reduce 90.59% | 39,891 | $581.21 |
| Q2 2024 | +296,646 | Add 743.64% | 336,537 | $553.00 |
| Q3 2024 | -336,537 | Sold Out | 336,537 | $553.00 |
| Q4 2024 | +39,097 | New Buy | 39,097 | $520.23 |
| Q1 2025 | -297 | Reduce 0.76% | 38,800 | $497.60 |
| Q2 2025 | +332,540 | Add 857.06% | 371,340 | $405.46 |
| Q3 2025 | -201,889 | Reduce 54.37% | 169,451 | $485.02 |
Steven Cohen's Thermo Fisher Scientific Investment FAQs
Steven Cohen first purchased Thermo Fisher Scientific Inc. (TMO) in Q2 2014, acquiring 148,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Thermo Fisher Scientific Inc. (TMO) for 38 quarters since Q2 2014.
Steven Cohen's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q4 2023, adding 423,803 shares worth $224.95 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 169,451 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $82.19 M.
As of the Q3 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 0.14% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Thermo Fisher Scientific Inc. (TMO) was 423,803 shares, as reported at the end of Q4 2023.